Your search returned 5 results.

Results
	1.	The pharmacokinetics of darexaban are not affected to a clinically relevant degree by rifampicin, a strong inducer of P-glycoprotein and CYP3A4. [electronic resource] by Groenendaal, Dorien Strabach, Gregory Garcia-Hernandez, Alberto Kadokura, Takeshi Heeringa, Marten Mol, Roelof Eltink, Charlotte Onkels, Hartmut Producer: 20130701 In: British journal of clinical pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol. [electronic resource] by Krauwinkel, Walter Dickinson, James Schaddelee, Marloes Meijer, John Tretter, Reiner van de Wetering, Jeroen Strabach, Gregory van Gelderen, Marcel Producer: 20140703 In: European journal of drug metabolism and pharmacokinetics vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The pharmacokinetics of darexaban (YM150), an oral direct factor Xa inhibitor, are not affected by ketoconazole, a strong inhibitor of CYP3A and P-glycoprotein. [electronic resource] by Groenendaal, Dorien Strabach, Gregory Garcia-Hernandez, Alberto Kadokura, Takeshi Heeringa, Marten Mol, Roelof Eltink, Charlotte Onkels, Hartmut Producer: 20180122 In: Clinical pharmacology in drug development vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects. [electronic resource] by Krauwinkel, Walter J J Kerbusch, Virginie M M Meijer, John Tretter, Reiner Strabach, Gregory Van Gelderen, E Marcel Producer: 20160429 In: Clinical pharmacology in drug development vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. [electronic resource] by Krauwinkel, Walter van Dijk, Jan Schaddelee, Marloes Eltink, Charlotte Meijer, John Strabach, Grégory van Marle, Sjoerd Kerbusch, Virginie van Gelderen, Marcel Producer: 20130322 In: Clinical therapeutics vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)